Regulatory
Matters |
|
Benfluorex |
|
Ceftriaxone |
|
Clopidogrel |
|
Cough
and cold medicines |
|
Cyproterone
acetate |
|
Desipramine
hydrochloride |
|
Diclofenac
sodium |
|
Etravirine |
|
Exenatide |
|
Fosamprenavir
calcium |
|
Gadoversetamide |
|
Iron
dextran injection |
|
Local
anesthetics |
|
Natalizumab |
|
Orciprenaline
sulphate |
|
Oseltamivir |
|
Promethazine
injection |
|
Sibutramine |
|
Sitagliptin |
|
Sleep-aid
medicines |
|
Statins |
|
Valproate |
|
Vigabatrin |
|
Warfarin |
Safety of Medicines |
|
Alendronate |
|
Antidepressants |
|
Bisphosphonates |
|
Colchicine |
|
Deferasirox |
|
Finasteride |
|
Gadolinium-containing
contrast agents |
|
H1N1
pandemic vaccines |
|
Human
insulin and insulin analogues |
|
Immune
globulin |
|
Lamotrigine |
|
Metoclopramide |
|
Phenytoin |
|
Rituximab |
|
SSRIs/SNRIs
and thiazide diuretics |
|
Zanamivir |
Feature |
|
Drotrecogin
alfa - Thrombosis |